Associations of abdominal visceral and subcutaneous adipose tissue with clinical and computed tomography imaging markers of metabolic syndrome

Aim: Central obesity comprises visceral (VAT) and subcutaneous (SAT) adipose tissues, which were reported to have associations with metabolic syndrome. Abdominal computed tomography (CT) scan allows evaluation of VAT, SAT, hepatosteatosis, pancreatic steatosis, and aortoiliac atherosclerosis. We aim to investigate the relationship between central obesity components (VAT, SAT) and metabolic syndrome imaging markers that are detectable on abdominal CT and the predictive power of these parameters for detecting hypertension (HT), diabetes mellitus (DM), and dyslipidemia (DL). Materials and Methods: Abdominal CT scans of 321 patients were evaluated for VAT, SAT volumes, hepatosteatosis, pancreatic steatosis, and aortoiliac atherosclerosis in this retrospective cross-sectional study. The associations of VAT, SAT, and visceral-tosubcutaneous fat (V/S) ratio with HT, DM, DL, hepatosteatosis, pancreatic steatosis, and aortoiliac atherosclerosis were investigated by Mann-Whitney U test, Kendall's Tau-b test, and boosting linear regression analysis. Cut-off values of VAT, SAT, and V/S ratio were calculated to predict HT, DM, DL, hepatosteatosis, pancreatic steatosis, and aortoiliac atherosclerosis by receiver operating characteristic (ROC) curve analysis. Results: Increased VAT volume and V/S ratio were significantly related to HT, DM, DL, hepatosteatosis, pancreatic steatosis, and aortoiliac atherosclerosis (p

PDF

___

1. Jensen MD, Ryan DH, Apovian CM, et al. 2013 AHA/ ACC/TOS guideline for the management of overweight and obesity in adults: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines and The Obesity Society. Circulation 2014;129:S102-38.
2. Bosomworth NJ. Normal-weight central obesity. Can Fam Physician 2019;65:399-408.
3. Bays HE, González-Campoy JM, Bray GA, et al. Pathogenic potential of adipose tissue and metabolic consequences of adipocyte hypertrophy and increased visceral adiposity. Expert Rev Cardiovasc Ther 2008;6:343-68.
4. Tang L, Zhang F, Tong N. The association of visceral adipose tissue and subcutaneous adipose tissue with metabolic risk factors in a large population of Chinese adults. Clin Endocrinol 2016;85:46-53.
5. Fox CS, Massaro JM, Hoffmann U, et al. Abdominal visceral and subcutaneous adipose tissue compartments: association with metabolic risk factors in the Framingham Heart Study. Circulation 2007;116:39-48.
6. Chait A, den Hartigh LJ. Adipose Tissue Distribution, Inflammation and Its Metabolic Consequences, Including Diabetes and Cardiovascular Disease. Front Cardiovasc Med 2020;7:22,
7. Wells MM, Li Z, Addeman B, et al. Computed Tomography Measurement of Hepatic Steatosis: Prevalence of Hepatic Steatosis in a Canadian Population. Can J Gastroenterol Hepatol 2016;2016:4930987.
8. Mathur A, Marine M, Lu D, et al. Nonalcoholic fatty pancreas disease. HPB 2007;9:312-8.
9. Akturk Y, Gunes SO. Computed tomography assessment of pancreatic steatosis in association with anthropometric measurements: A retrospective cohort study. Arch Clin Exp Med 2018;3:63-6.
10. Ong K-L, McClelland RL, Rye K-A, et al. The relationship between insulin resistance and vascular calcification in coronary arteries, and the thoracic and abdominal aorta: the Multi-Ethnic Study of Atherosclerosis. Atherosclerosis 2014;236:257-62.
11. Ozturk C, Gungor O, Kaplanoglu V, et al. Relationship between Abdominal Aortic Calcification, Abdominal Adiposity, and Liver Density. J Coll Physicians Surg Pak 2020;30:1245-50.
12. Kure T, Mawatari S, Imamura Y, et al. Nonalcoholic fatty liver disease is associated with both subcutaneous and visceral adiposity: A cross-sectional study. Medicine 2019;98:e17879.
13. Park SH, Kim PN, Kim KW, et al. Macrovesicular hepatic steatosis in living liver donors: use of CT for quantitative and qualitative assessment. Radiology 2006;239:105-12.
14. Kim SY, Kim H, Cho JY, et al. Quantitative assessment of pancreatic fat by using unenhanced CT: pathologic correlation and clinical implications. Radiology 2014;271:104-12.
15. Neeland IJ, Ayers CR, Rohatgi AK, et al. Associations of visceral and abdominal subcutaneous adipose tissue with markers of cardiac and metabolic risk in obese adults. Obesity 2013;21:E439-447.
16. Liu J, Fox CS, Hickson DA, et al. Impact of abdominal visceral and subcutaneous adipose tissue on cardiometabolic risk factors: the Jackson Heart Study. J Clin Endocrinol Metab 2010;95:5419-26.
17. Ding J, Visser M, Kritchevsky SB, et al. The association of regional fat depots with hypertension in older persons of white and African American ethnicity. Am J Hypertens 2004;17:971-6.
18. Sullivan CA, Kahn SE, Fujimoto WY, Hayashi T, Leonetti DL, Boyko EJ. Change in Intra-Abdominal Fat Predicts the Risk of Hypertension in Japanese Americans. Hypertension 1979 2015;66:134-40.
19. Oka R, Yagi K, Sakurai M, et al. Impact of visceral adipose tissue and subcutaneous adipose tissue on insulin resistance in middle-aged Japanese. J Atheroscler Thromb 2012;19:814-22.
20. Mosca L, Barrett-Connor E, Wenger NK. Sex/Gender Differences in Cardiovascular Disease Prevention What a Difference a Decade Makes. Circulation 2011;124:2145-54.
21. Goodpaster BH, Krishnaswami S, Harris TB, et al. Obesity, regional body fat distribution, and the metabolic syndrome in older men and women. Arch Intern Med 2005;165:777-83.